ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02752074
Brief Title: A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

First Submitted : April 22, 2016
First Submitted that Met QC Criteria : April 22, 2016
First Posted : April 26, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 2, 2018
Last Update Posted : May 8, 2018